UNSPSC 41141612: Chymotrypsin

In this classification, this entry connotes a Chymotrypsin enzyme that is used in clinical chemistry testing.

UNSPSC 41141612 Chymotrypsin, a Commodity code, does not align with the state and local procurement activity recorded under this designation. The recent opportunities linked to this code span laboratory reagents, sequencing consumables, extraction media, and analytical standards for public health testing — chiefly respiratory pathogen detection, foodborne pathogen sequencing, drinking-water contaminant analysis, and forensic chemistry — none of which involve chymotrypsin or protease-based diagnostic reagents. The mismatch suggests either a tagging error in the underlying procurement system or that the code's nominal scope diverges substantially from current market demand. Texas Health and Human Services Commission (HHSC) and the Department of State Health Services (DSHS) dominate the recent solicitation volume, with multiple IFBs posted in 2026 for consumables supporting next-generation sequencing platforms (Illumina MiSeq and iSeq, Clear Labs Dx systems), culture media and enrichment kits, and chromatography standards and extraction disks. The Mississippi State Department of Health, City of Philadelphia, University of Texas Health Science Center at San Antonio, and State of California round out the issuing-body mix, reflecting state health laboratories, municipal procurement, higher-education research, and statewide forensic and diagnostic supply chains.

Texas dominates recent activity, with ten of fourteen opportunities originating from HHSC/DSHS for drinking-water testing standards, wastewater surveillance reagents, and WGS (whole genome sequencing) consumables. Mississippi accounts for two sole-source procurements (Clear Labs and Illumina WGS reagent bundles) for the Mississippi Public Health Laboratory, while California issued two brand-name-restricted RFBs for mycobacterial diagnostic reagents (MyCodeDR) and forensic spiking solutions (Cerilliant). Representative recent opportunities include HHSC IFB HHS0017272 (posted June 25, 2026; due May 19, 2026) for Illumina Viral Surveillance Panel v2 kits and respiratory pathogen enrichment consumables with a historical spend range of $35,050 to $90,000; HHSC IFB HHS0017132 (posted June 2, 2026; due June 2, 2026) for culture media (R&F brand) for E. coli O157:H7, Listeria, and Enterobacter detection, with historical FY2026 spend of $187,340; and the University of Texas Health Science Center at San Antonio RFP 745-26-P19 (posted May 7, 2026; due June 4, 2026) for a comprehensive biotech research and clinical diagnostics equipment and reagent catalog with approximately 8,768 line items ordered in the prior contract year. The code shows active demand but little relevance to chymotrypsin procurement; bidders should verify actual commodity requirements in the RFP narrative before pursuing awards under this designation.